XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.06

+0.3%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (10634)	7/7/1999 9:59:00 AM
From: aknahow	Read Replies (1) of 17367

Results were great. Not knocking them but just interested if any of us can find out what the results were at the longer look back period of 141 days. As given the results were at 56 days. <<<<<<<< Analysis of data from the study showed that 48% of patients treated with the 0.3 mg/kg dose of the product showed a Physician's Global Assessment (PGA) score at 56 days of 50% or greater improvement (''good'' or better) compared with 15% of placebo patients (p = 0.0002, Fisher's Exact test) and 25% had a PGA score of 75% or greater improvement (''excellent'') compared with 2% of the placebo group (p = 0.0004). On the whole, the drug appeared to be well tolerated. The most common adverse events were mild headaches and low-grade fever, particularly after the first dose. >>>>>>>>>>>>>>>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next